Clinical Trial Update: Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide plus low-dose dexamethasone followed by stem cell collection and randomization to continued therapy or stem cell transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Dexamethasone (low-dose) (dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2019-03-15